Skip to content
StockMarketAgent
Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

USPH stock hub

U.S. Physical Therapy, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

USPHis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
902.3M
NYSE
Market data

Live price

Current market quote for this ticker.

Current price
USPH
In the news

Latest news · USPH

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E20.2
P25 12.6P50 18.3P75 33.7
Trailing P/E117.4
P25 15P50 23.3P75 38.5
ROE6.8
P25 -106.6P50 -46.9P75 -3.1
ROIC5.5
P25 -63.1P50 -27.5P75 -0
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All USPH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
267
Groups with data
11
Currency
USD
Showing 267 of 267 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0000885978
Company name
U.S. Physical Therapy, Inc.
Country
United States
Country code
US
Cusip
90337L108
Employees
8,095
Employees Change
1,067%
Employees Change Percent
15.18
Enterprise value
$1.2B
Exchange
NYSE
Financial currency
USD
First seen
2026-05-09
Industry
Medical Care Facilities
IPO Date
1992-05-28
Isin
US90337L1089
Last refreshed
2026-05-10
Market cap
$902.3M
Market cap category
Small-Cap
Price
$59.29
Price currency
USD
Rev Per Employee
97,305.13x
Sector
Healthcare
Sic
8000
Symbol
USPH
Website
https://www.usph.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

17
MetricValue
Earnings Yield
0.85%
EV Earnings
161.15x
EV Sales Forward
1.43x
EV/EBIT
15.44x
EV/EBITDA
12.05x
EV/FCF
18.53x
EV/Sales
1.57x
FCF yield
7.39%
Forward P/E
20.17x
P/B ratio
1.93x
P/E ratio
117.4x
P/S ratio
1.15x
PE Ratio10 Y
53.19x
PE Ratio3 Y
69.55x
PE Ratio5 Y
57.52x
PEG ratio
1.82x
PS Forward
1.04x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

26
MetricValue
EBIT Margin
10.16%
EBITDA Margin
13.02%
FCF margin
8.46%
Gross margin
21.9%
Gross Profit
$172.5M
Gross Profit Growth
14.58%
Gross Profit Growth Q
4.06%
Gross Profit Growth3 Y
14.05%
Gross Profit Growth5 Y
10.48%
Net Income
$7.7M
Net Income Growth
4.34%
Net Income Growth Q
-49.11%
Net Income Growth Years
2%
Net Income Growth3 Y
-35.12%
Net Income Growth5 Y
-24.83%
Pretax Margin
9.02%
Profit Margin
4.41%
Profit Per Employee
$947
Profitable Years
31
ROA
4.13
Roa5y
4.94
ROCE
7.12
ROE
6.83
Roe5y
8.66
ROIC
5.48
Roic5y
7.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

26
MetricValue
Cagr10y
1.91%
Cagr15y
8.07%
Cagr1y
-14.46%
Cagr20y
8.4%
Cagr3y
-17.95%
Cagr5y
-11.39%
Div CAGR10
11.02%
Div CAGR3
2.7%
Div CAGR5
21.06%
EPS Growth
-76.77
EPS Growth Years
0
EPS Growth3 Y
-38.36
EPS Growth5 Y
-27.29
FCF Growth
19.24%
FCF Growth3 Y
9.74%
FCF Growth5 Y
-6.8%
OCF Growth
26.87%
OCF Growth10 Y
5.47%
OCF Growth3 Y
12.78%
OCF Growth5 Y
-3.78%
Revenue Growth
13.77x
Revenue Growth Q
7.88x
Revenue Growth Quarters
20x
Revenue Growth Years
5x
Revenue Growth3 Y
11.77x
Revenue Growth5 Y
13.5x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
$0.65
Assets
$1.2B
Cash
$29.5M
Current Assets
$139.1M
Current Liabilities
$117.3M
Debt
$362.8M
Debt EBITDA
$2.21
Debt Equity
$0.46
Debt FCF
$5.44
Equity
$782.9M
Interest Coverage
8.03
Liabilities
$459.2M
Long Term Assets
$1.1B
Long Term Liabilities
$341.9M
Net Cash
$-333.3M
Net Cash By Market Cap
$-36.94
Net Debt EBITDA
$3.25
Net Debt Equity
$0.43
Net Debt FCF
$5
Tangible Book Value
$-426.7M
Tangible Book Value Per Share
$-28.02
WACC
8.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
1.19
Net Working Capital
$45.9M
Quick ratio
1.08
Working Capital
$21.8M
Working Capital Turnover
$36.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.6%
Dividend Growth
2.25%
Dividend Growth Years
5%
Dividend per share
$1.84
Dividend Years
16
Dividend Yield
3.1%
Ex Div Date
2026-05-22
Last Dividend
$0.46
Payout Frequency
Quarterly
Payout Ratio
360.39%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
20.76%
1Y total return
-14.45%
200-day SMA
80.41
3Y total return
-44.76%
50-day SMA
75.58
50-day SMA vs 200-day SMA
50under200
5Y total return
-45.35%
All Time High
148.5
All Time High Change
-60.07%
All Time High Date
2019-11-05
All Time Low
1.42
All Time Low Change
4,084.19%
All Time Low Date
1992-10-07
ATR
3.59
Beta
1.2
Beta1y
1.34
Beta2y
1.01
Ch YTD
-24.07
High
62.34
High52
93.5
High52 Date
2025-10-24
High52ch
-36.59%
Low
58.19
Low52
58.19
Low52 Date
2026-05-08
Low52ch
1.89%
Ma50ch
-21.55%
Price vs 200-day SMA
-26.26%
RSI
21.01
RSI Monthly
36.46
RSI Weekly
27.67
Sharpe ratio
-0.29x
Sortino ratio
-0.25
Total Return
2.5%
Tr YTD
-23.62
Tr15y
220.25%
Tr1m
-20.8%
Tr1w
-17.46%
Tr3m
-30.31%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

14
MetricValue
Analyst Count
4
Analyst Ratings
Strong Buy
Earnings EPS Estimate
$0.52
Earnings EPS Estimate Growth
8.33
Earnings Revenue Estimate
201,452,904x
Earnings Revenue Estimate Growth
9.61x
Operating Income
$80.1M
Operating Income Growth
13.38
Operating Income Growth Q
-4.33
Operating Income Growth3 Y
5.65
Operating Income Growth5 Y
4.71
Operating margin
10.16
Price target
$101
Price Target Change
$69.93

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
14,860,954%
Float Percent
97.65%
Net Borrowing
36,833,000
Shares Insiders
2.41%
Shares Institutions
107.34%
Shares Out
15,218,789
Shares Qo Q
0%
Shares Yo Y
0.6%
Short Float
6.65%
Short Ratio
7.05
Short Shares
6.49

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

72
MetricValue
Adjusted FCF
$57.9M
Average Volume
185,492.85x
Bv Per Share
30.79
CAPEX
$-16.9M
Ch10y
4.98
Ch15y
155.5
Ch1m
-20.8
Ch1w
-17.46
Ch1y
-16.45
Ch20y
298.5
Ch3m
-30.72
Ch3y
-48.04
Ch5y
-50.24
Ch6m
-19.74
Change
0.49%
Change From Open
0.97
Close
59
Days Gap
-0.47
Depreciation Amortization
22,524,000
Dollar Volume
17,615,889.1
Earnings Date
2026-05-06
Earnings Time
amc
EBIT
$80.1M
EBITDA
$102.6M
EPS
$0.51
F Score
7
FCF
$66.7M
FCF EV Yield
5.4x
FCF Per Share
$4.38
Financing CF
-24,399,000
Fiscal Year End
December
Founded
1,990
Goodwill
715,874,000
Graham Number
18.70519
Graham Upside
-68.45
Income Tax
$18.4M
Investing CF
-69,886,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-06
Last Report Date
2026-03-31
Last Split Date
2001-06-29
Last Split Type
Forward
Last10k Filing Date
2026-02-27
Lynch Fair Value
$2.53
Lynch Upside
-95.74
Ma150
80.02
Ma150ch
-25.9%
Ma20
72.84
Ma20ch
-18.6%
Net CF
-10,744,000
Next Earnings Date
2026-08-05
Open
58.72
Optionable
Yes
P FCF Ratio
13.53
P OCF Ratio
10.8
Payment Date
2026-06-12
Position In Range
26.51
Ppne
187,824,000
Price Date
2026-05-08
Price EBITDA
$8.8
Relative Volume
1.6x
Revenue
787,685,000x
SBC By Revenue
1.12x
Share Based Comp
8,809,000
Tax By Revenue
2.33x
Tax Rate
25.83%
Tr20y
401.48%
Tr6m
-18.75%
Us State
Texas
Volume
297,114
Z Score
2.69
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

USPH dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+3.1%
$1.84 annual per share
Payout ratio
+360.4%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+21.1%
5 consecutive years of growth
Total shareholder yield
+2.5%
Next ex-dividend date: 2026-05-22
Performance

USPH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-14.5%
S&P 500 1Y: n/a
3Y total return
-44.8%
S&P 500 3Y: n/a
5Y total return
-45.4%
S&P 500 5Y: n/a
10Y total return
+20.8%
S&P 500 10Y: n/a
Ownership

Who owns USPH?

Insider, institutional, and short-interest positioning.

Institutional ownership
+107.3%
Float: +97.6% of shares outstanding
Insider ownership
+2.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+6.6%
7.0 days to cover
Y/Y dilution
+0.6%
Negative means the company is buying back shares.
Technical

USPH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
21.0
Below 30: short-term oversold
Price vs 200-day MA
-26.3%
50/200-day relationship not available
Beta (5Y)
1.20
More volatile than the market
Sharpe ratio
-0.29
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About USPH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current USPH stock rating?

U.S. Physical Therapy, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full USPH analysis?

The full report lives at /stocks/USPH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for USPH?

The latest report frames USPH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the USPH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.